Description

SEBI issues a completion certificate for Recovery Certificate No. 6648 of 2023 against Sadanand Prayag Mishra (PAN: AFVPM2400E) in the matter of Shreekrishna Biotech Limited, signifying successful recovery of dues.

Summary

SEBI has issued a Completion Certificate for Recovery Certificate No. 6648 of 2023 against Sadanand Prayag Mishra (PAN: AFVPM2400E) in the matter of Shreekrishna Biotech Limited. This order signifies that the recovery proceedings have been successfully concluded, meaning the outstanding dues under the recovery certificate have been fully paid or otherwise satisfied.

Key Points

  • Recovery Certificate No. 6648 of 2023 issued against Sadanand Prayag Mishra (PAN: AFVPM2400E)
  • Matter pertains to Shreekrishna Biotech Limited
  • SEBI has issued a Completion Certificate, indicating successful conclusion of recovery proceedings
  • The completion certificate confirms that all dues under the recovery certificate have been satisfied
  • This closes out the enforcement/recovery action against the named individual

Regulatory Changes

No regulatory changes are introduced by this order. This is an administrative completion certificate concluding an existing enforcement action.

Compliance Requirements

No new compliance requirements are imposed. The issuance of the completion certificate signifies that the subject party (Sadanand Prayag Mishra) has fulfilled the obligations under Recovery Certificate No. 6648 of 2023.

Important Dates

  • Recovery Certificate No. 6648 issued: 2023
  • Completion Certificate issued: February 2026

Impact Assessment

This order has minimal market or operational impact. It is a routine administrative document confirming the closure of a specific enforcement/recovery matter involving an individual in connection with Shreekrishna Biotech Limited. No broader market participants or trading activities are affected.

Impact Justification

Routine administrative completion certificate confirming recovery of dues from an individual in an older enforcement matter; no new regulatory changes or broad market impact.